PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25262337-6	2014	Blocking IP3R with antagonists or silencing pan-IP3R expression with shRNA hindered the 6-carboxyfluorescein (6-CFDA) diffusion through GJs and desynchronized Ca2+ transients among confluent neonatal myocytes in culture, whereas stimulation of IP3R with IP3 ester or ATP exerted the opposite effect.	6-carboxyfluorescein	88-108	inositol 1,4,5-trisphosphate receptor type 3	Homo sapiens	9-13	
25262337-6	2014	Blocking IP3R with antagonists or silencing pan-IP3R expression with shRNA hindered the 6-carboxyfluorescein (6-CFDA) diffusion through GJs and desynchronized Ca2+ transients among confluent neonatal myocytes in culture, whereas stimulation of IP3R with IP3 ester or ATP exerted the opposite effect.	6-carboxyfluorescein	88-108	inositol 1,4,5-trisphosphate receptor type 3	Homo sapiens	48-52	
25262337-6	2014	Blocking IP3R with antagonists or silencing pan-IP3R expression with shRNA hindered the 6-carboxyfluorescein (6-CFDA) diffusion through GJs and desynchronized Ca2+ transients among confluent neonatal myocytes in culture, whereas stimulation of IP3R with IP3 ester or ATP exerted the opposite effect.	6-carboxyfluorescein	88-108	inositol 1,4,5-trisphosphate receptor type 3	Homo sapiens	48-52